设为首页| 加入收藏
网站首页 本刊简介 编委会 投稿指南 过刊浏览 联系我们 下载专区
最新消息:
位置:首页 >> 期刊文章
非酒精性脂肪性肝病治疗进展
作者:刘玉凤   谢雯 
单位:首都医科大学附属北京地坛医院 肝病中心 北京 100015 
关键词:脂肪肝 非酒精性性 生活方式干预 减肥手术 药物疗法 
分类号:
出版年,卷(期):页码:2016,8(1):26-28
摘要:

摘要:非酒精性脂肪性肝病是一种与胰岛素抵抗及遗传易感性密切相关的代谢应激性疾病。随着人
们生活水平的不断提高,患病率呈不断上升趋势。非酒精性脂肪性肝病不仅可导致转氨酶持续异
常、失代偿期肝硬化、肝功能衰竭等严重肝病,也与心血管疾病、2型糖尿病、代谢综合征的发生存
在密切联系,严重威胁着人们的健康。因此,非酒精性脂肪性肝病的治疗越来越受到重视,其治疗
原则包括:①去除病因,治疗原发基础病;②基础治疗:生活方式干预、饮食调整及运动治疗等基
本措施;③针对不同的病理学特征,因人而异予辅助药物治疗;④终末期行肝移植治疗。本文将重
点对生活方式干预、减肥手术及药物治疗的进展状况进行综述。

Abstract: Non-alcoholic fatty liver disease is a metabolic stress disorder which is closely related to insulin
resistance and genetic susceptibility. As the living standards continue improving, the prevalence has been rising.
Non-alcoholic fatty liver disease can not only cause seriously abnormal liver transaminases, decompensated
cirrhosis, liver failure and so on, but also is associated with cardiovascular disease, type 2 diabetes and metabolic
syndrome, which is a serious threat to the health of people. Therefore, the treatment of non-alcoholic fatty
liver disease causes more and more attention, and the treatment principles include: ①Removal of the cause
and to treat the primary underlying diseases; ②Basic measures of treatment: lifestyle intervention, dietary
modification, exercise therapy and so on; ③To give a supplementary drug therapy varying from person
to person according to different pathologic features; ④For end-stage liver disease, liver transplantation is
recommend. This article will focus on lifestyle interventions, weight loss surgery and drug treatment progress.

基金项目:
作者简介:
参考文献:
服务与反馈:
文章下载】【加入收藏
 

地址:北京市朝阳区京顺东街8号
邮政编码:100015  电话:010-84322058  传真:010-84322059 Email:editordt@163.com